﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>15</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2025</Year>
        <Month>01</Month>
        <DAY>19</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Role of Toll-like receptors in exosome biogenesis and angiogenesis capacity</ArticleTitle>
    <FirstPage>30333</FirstPage>
    <LastPage>30333</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.30333</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Parisa</FirstName>
        <LastName>Hassanpour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1088-153X</Identifier>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Sadeghsoltani</LastName>
      </Author>
      <Author>
        <FirstName>Mir‑Meghdad</FirstName>
        <LastName>Safari</LastName>
      </Author>
      <Author>
        <FirstName>Sanya</FirstName>
        <LastName>Haiaty</LastName>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Rahbarghazi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-3864-9166</Identifier>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Mota</LastName>
      </Author>
      <Author>
        <FirstName>Mohamad</FirstName>
        <LastName>Rahmati</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.30333</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>02</Month>
        <Day>06</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>04</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <Abstract>Adaptive inflammation consists of multiple cellular changes and molecular reactions to protect host cells against several pathological conditions. Along with the activation of varied immune cells, the production and secretion of cytokines arrays can regulate the progression of inflammatory response in a paracrine manner. Among different molecular cascades, Toll-like receptors (TLRs) are activated in response to several pathological conditions and damage signals. It has been indicated that extracellular vesicles, especially exosomes (Exos) are key bioshuttles with specific cargoes and are involved in cell-to-cell communication. The role of Exos in the initiation, progression, and cession of inflammation has been previously addressed in terms of cytokine transmission. Whether and how the activation of TLRs can alter the Exo biogenesis and angiogenesis potential in immune cells and endothelial cells (ECs) remains to be elucidated. Here, the cross-talk between the TLRs, Exo biogenesis, and angiogenesis has been highlighted.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Toll-like receptors</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Exosomes</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Exocytosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Angiogenesis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Endothelial cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Immune cells</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>